"Indinavir" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A potent and specific HIV protease inhibitor that appears to have good oral bioavailability.
Descriptor ID |
D019469
|
MeSH Number(s) |
D03.383.725.385
|
Concept/Terms |
L-735 524- L-735 524
- L 735 524
- L735 524
- L-735,524
- L 735,524
- L735,524
|
Below are MeSH descriptors whose meaning is more general than "Indinavir".
Below are MeSH descriptors whose meaning is more specific than "Indinavir".
This graph shows the total number of publications written about "Indinavir" by people in this website by year, and whether "Indinavir" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 1 | 0 | 1 |
2002 | 1 | 0 | 1 |
2004 | 1 | 1 | 2 |
2007 | 0 | 1 | 1 |
2010 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Indinavir" by people in Profiles.
-
HIV-1 protease mutations and protease inhibitor cross-resistance. Antimicrob Agents Chemother. 2010 Oct; 54(10):4253-61.
-
Indinavir-induced nephrolithiasis three and one-half years after cessation of indinavir therapy. Int Urol Nephrol. 2011 Jun; 43(2):571-3.
-
Effects of ritonavir and amprenavir on insulin sensitivity in healthy volunteers. AIDS. 2007 Oct 18; 21(16):2183-90.
-
Indinavir increases glucose production in healthy HIV-negative men. AIDS. 2004 Sep 03; 18(13):1852-4.
-
HIV protease inhibitors increase adiponectin levels in HIV-negative men. J Acquir Immune Defic Syndr. 2004 May 01; 36(1):645-7.
-
Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study. AIDS. 2002 Mar 29; 16(5):F1-8.
-
Metabolic effects of indinavir in healthy HIV-seronegative men. AIDS. 2001 May 04; 15(7):F11-8.